XL-820

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameXL-820
Drug Alias NameXL-820
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor subunit A inhibitorsVascular endothelial growth factor receptor antagonistsStem cell growth factor receptor inhibitors +[5] 
TargetsStem cell growth factor receptorPlatelet-derived growth factor subunit BPlatelet-derived growth factor subunit A +[5] 
Therapy Area/IndicationsGastrointestinal NeoplasmsGastrointestinal Stromal TumorsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExelixis Inc
Active IndicationsN/A
Inactive IndicationsGastrointestinal NeoplasmsGastrointestinal Stromal TumorsNeoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank